JP2007532915A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532915A5
JP2007532915A5 JP2007508545A JP2007508545A JP2007532915A5 JP 2007532915 A5 JP2007532915 A5 JP 2007532915A5 JP 2007508545 A JP2007508545 A JP 2007508545A JP 2007508545 A JP2007508545 A JP 2007508545A JP 2007532915 A5 JP2007532915 A5 JP 2007532915A5
Authority
JP
Japan
Prior art keywords
subject
amount
tbi
csf
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007508545A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532915A (ja
JP4659025B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/012746 external-priority patent/WO2005106038A2/en
Publication of JP2007532915A publication Critical patent/JP2007532915A/ja
Publication of JP2007532915A5 publication Critical patent/JP2007532915A5/ja
Application granted granted Critical
Publication of JP4659025B2 publication Critical patent/JP4659025B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007508545A 2004-04-15 2005-04-15 神経系傷害および他の神経障害についての生物マーカーとしての神経タンパク質 Expired - Lifetime JP4659025B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56294404P 2004-04-15 2004-04-15
PCT/US2005/012746 WO2005106038A2 (en) 2004-04-15 2005-04-15 Neural proteins as biomarkers for nervous system injury and other neural disorders

Publications (3)

Publication Number Publication Date
JP2007532915A JP2007532915A (ja) 2007-11-15
JP2007532915A5 true JP2007532915A5 (enExample) 2008-05-08
JP4659025B2 JP4659025B2 (ja) 2011-03-30

Family

ID=35242271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007508545A Expired - Lifetime JP4659025B2 (ja) 2004-04-15 2005-04-15 神経系傷害および他の神経障害についての生物マーカーとしての神経タンパク質

Country Status (7)

Country Link
US (2) US7396654B2 (enExample)
EP (2) EP1745149A4 (enExample)
JP (1) JP4659025B2 (enExample)
AU (1) AU2005238446B2 (enExample)
CA (2) CA2578670C (enExample)
ES (1) ES2482142T3 (enExample)
WO (1) WO2005106038A2 (enExample)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1519194A1 (en) 2003-09-24 2005-03-30 Roche Diagnostics GmbH Use of gfap for identification of intracerebral hemorrhage
EP2314218B1 (en) * 2004-02-06 2017-02-01 Wake Forest University Health Sciences Non-invasive imaging for determining global tissue characteristics
US7747308B2 (en) * 2004-02-06 2010-06-29 Wake Forest University Health Sciences Non-invasive systems and methods for the determination of cardiac injury using a characterizing portion of a voxel histogram
JP4885122B2 (ja) * 2004-04-15 2012-02-29 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 癌、器官傷害、および筋肉リハビリテーション/運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
CA2571445C (en) * 2004-06-25 2015-07-28 Washington University Markers for brain damage
WO2006107846A2 (en) * 2005-04-01 2006-10-12 University Of Florida Research Foundation, Inc. Biomakers of liver injury
US8048638B2 (en) 2005-04-01 2011-11-01 University Of Florida Research Foundation, Inc. Biomarkers of liver injury
WO2007092159A2 (en) 2006-02-02 2007-08-16 Wake Forest University Health Sciences Cardiac visualization systems for displaying 3-d images of cardiac voxel intensity distributions with optional physician interactive boundary tracing tools
EP1815863A1 (en) * 2006-02-03 2007-08-08 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Use of TLR3 agonists for the treatment of neurodegenerative disorders
EP1840574A1 (en) * 2006-03-30 2007-10-03 Institut Pasteur Use of the alpha chain of brain spectrin and fragments thereof, for diagnosing cerebral diseases
EP2021792B1 (en) * 2006-05-09 2013-02-27 The University Of British Columbia Dissolved protein arthritis markers
WO2007136617A2 (en) 2006-05-18 2007-11-29 Walter Reed Army Institute Of Research (Wrair) Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
DE102006033294A1 (de) * 2006-07-17 2008-01-31 Evotec Technologies Gmbh Analyseverfahren für chemische und/oder biologische Proben
WO2008097618A1 (en) * 2007-02-06 2008-08-14 University Of Florida Research Foundation, Inc. Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
WO2008124096A1 (en) * 2007-04-04 2008-10-16 Gaia Medical Institute Systems and methods for analyzing persistent homeostatic perturbations
JP2009052933A (ja) * 2007-08-24 2009-03-12 Rakuno Gakuen プリオン病の検出方法及び診断キット
KR101945394B1 (ko) 2007-11-27 2019-02-07 더 유니버시티 오브 브리티쉬 콜롬비아 관절염의 진단과 치료를 위한 14-3-3 에타 항체 및 이의 용도
WO2009094713A1 (en) * 2008-01-29 2009-08-06 Murdoch Childrens Research Institute Diagnosis and treatment of sensory defect
EP2245466A2 (en) 2008-02-04 2010-11-03 Banyan Biomarkers, Inc. Process to diagnose or treat brain injury
US20140342381A1 (en) * 2008-08-11 2014-11-20 Banyan Biomarkers, Inc. Devices and methods for biomarker detection process and assay of neurological condition
JP5781436B2 (ja) 2008-08-11 2015-09-24 バンヤン・バイオマーカーズ・インコーポレーテッド 神経学的状態のバイオマーカー検出方法およびアッセイ
RU2381505C1 (ru) * 2008-09-30 2010-02-10 Федеральное Государственное Учреждение "Государственный Научный Центр Дерматовенерологии Федерального Агентства По Высокотехнологичной Медицинской Помощи" Способ диагностики сифилиса с использованием метода прямого протеомного профилирования сыворотки крови
EP2891882B1 (en) 2008-12-05 2018-08-15 C2N Diagnostics Methods for measuring concentrations of biomolecules
ES2714216T3 (es) 2009-03-11 2019-05-27 Augurex Life Sciences Corp Composiciones y métodos para caracterizar afecciones artríticas
AU2010262952B2 (en) * 2009-06-19 2016-01-07 Banyan Biomarkers, Inc. Biomarker assay of neurological condition
US20120202231A1 (en) * 2009-07-18 2012-08-09 Kevin Ka-Wang Wang Synergistic biomarker assay of neurological condition using s-100b
WO2011032155A2 (en) 2009-09-14 2011-03-17 Banyan Biomarkers, Inc. Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
US9682132B2 (en) 2010-01-26 2017-06-20 Banyan Biomarkers, Inc Compositions and methods relating to argininosucccinate synthetase
AU2011235892B2 (en) * 2010-04-01 2016-07-07 Banyan Biomarkers, Inc. Markers and assays for detection of neurotoxicity
WO2011160096A2 (en) * 2010-06-17 2011-12-22 Banyan Biomarkers, Inc. Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition
WO2012051519A2 (en) * 2010-10-14 2012-04-19 The Johns Hopkins University Biomarkers of brain injury
WO2012071584A2 (en) * 2010-11-26 2012-05-31 Brigham And Women's Hospital, Inc. Method for assessing repetitive head injuries with tow-dimensional magnetic resonance spectorscopy
HRP20181175T1 (hr) 2011-03-11 2018-09-21 Vib Vzw Molekule i postupci za inhibiciju i otkrivanje proteina
JP2014518624A (ja) 2011-05-12 2014-08-07 ザ・ジョンズ・ホプキンス・ユニバーシティー ニューログラニン診断キットのためのアッセイ試薬
US9547014B2 (en) 2011-06-10 2017-01-17 Cornell University Immobilized protein system for rapid and enhanced multiplexed diagnostics
US20120322682A1 (en) * 2011-06-20 2012-12-20 William Marsh Rice University Brain injury biomarker panel
KR101333207B1 (ko) * 2011-07-13 2013-11-26 부산대학교 산학협력단 자궁내막증과 연관된 유전자 마커 및 이의 용도
EP2560008B1 (en) * 2011-08-18 2016-11-30 Korea Institute of Science and Technology Pharmaceutical compositions for preventing or treating degenerative brain disease and method of screening the same
CA2846625A1 (en) * 2011-09-14 2013-03-21 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Processes and kits to detect and monitor for diagnostic biomarkers for post traumatic stress disorder (ptsd) and to differentiate between suicidal and non-suicidal form of the disorder
JP6844939B2 (ja) 2011-10-21 2021-03-17 オ−グレックス ライフ サイエンシズ コーポレイション シトルリン化14−3−3由来の抗原、及び関節リウマチの診断におけるそれの使用
US11305023B2 (en) * 2011-11-11 2022-04-19 Sam Popinchalk Method for diagnostically imaging lesions in the peripheral nervous system
AU2012345902A1 (en) * 2011-12-02 2014-06-26 C2N Diagnostics Methods for measuring concentrations of biomolecules
AU2013230045A1 (en) * 2012-03-05 2014-09-11 Berg Llc Compositions and methods for diagnosis and treatment of pervasive developmental disorder
HK1206425A1 (en) 2012-03-13 2016-01-08 The Johns Hopkins University Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
CN104520435A (zh) 2012-04-02 2015-04-15 博格有限责任公司 基于细胞的探询式分析及其应用
CN102735834B (zh) * 2012-05-11 2014-09-03 中国兽医药品监察所 一种检测苯乙醇胺a的酶联免疫试剂盒
JP5984559B2 (ja) * 2012-07-31 2016-09-06 オリンパス株式会社 壊死細胞領域検出装置及びその方法、壊死細胞領域検出プログラム
WO2014023852A1 (en) 2012-08-10 2014-02-13 Istituto Superiore di Sanità Biomarkers
US9265458B2 (en) 2012-12-04 2016-02-23 Sync-Think, Inc. Application of smooth pursuit cognitive testing paradigms to clinical drug development
US9380976B2 (en) 2013-03-11 2016-07-05 Sync-Think, Inc. Optical neuroinformatics
EP3022322A4 (en) 2013-07-17 2017-05-17 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
US10082500B2 (en) 2013-08-22 2018-09-25 Franz Baudenbacher Device and method for detecting a target analyte
GB201319492D0 (en) * 2013-11-05 2013-12-18 Secr Defence Biomarkers for traumatic brain injury
AU2015255877B2 (en) * 2014-05-08 2020-03-26 Chdi Foundation, Inc. Methods and compositions for treating huntington's disease
WO2016032977A1 (en) * 2014-08-24 2016-03-03 Haskins William E Cns-specific biomarkers for cns diseases or injuries
WO2016040725A1 (en) 2014-09-11 2016-03-17 Berg Llc Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data
EP3029466A1 (en) * 2014-12-03 2016-06-08 Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca Methods for differentiating ischemic stroke from hemorrhagic stroke
EP3254106A4 (en) 2015-02-05 2018-10-03 Immunarray USA, Inc. Methods and compositions for diagnosing brain injury or neurodegeneration
US10667737B2 (en) 2015-03-23 2020-06-02 International Business Machines Corporation Monitoring a person for indications of a brain injury
US10244971B2 (en) * 2015-05-12 2019-04-02 International Business Machines Corporation Mouthguard for analysis of biomarkers for traumatic brain injury
EP3452832A4 (en) * 2016-05-06 2020-04-22 Duke University METHODS AND KITS FOR DIAGNOSIS AND TREATMENT OF DISEASES OR INJURIES OF THE NERVOUS SYSTEM
WO2017193115A1 (en) * 2016-05-06 2017-11-09 Nanosomix, Inc. Synaptic protein biomarkers and differential diagnosis of alzheimer's disease and other neurodegenerative disorders
CN110383068A (zh) * 2016-10-03 2019-10-25 雅培实验室 评估患者样品中uch-l1状态的改进方法
CN110366558A (zh) 2016-10-28 2019-10-22 班扬生物标记公司 针对泛素c末端水解酶l1(uch-l1)和胶质纤维酸性蛋白(gfap)的抗体及相关方法
RU2648515C1 (ru) * 2016-12-21 2018-03-26 Общество с ограниченной ответственностью "ДРД" Прогнозирование течения и исхода комы и посткоматозных бессознательных состояний (в том числе вегетативных) с помощью гемотестов
WO2018132791A1 (en) 2017-01-16 2018-07-19 The Regents Of The University Of California Treatment of neurodegenerative conditions by disruption of rhes
CA3052513A1 (en) 2017-03-23 2018-09-27 Abbott Laboratories Methods for aiding in the diagnosis and determination of the extent of traumatic brain injury in a human subject using the early biomarker ubiquitin carboxy-terminal hydrolase l1
US10877048B2 (en) 2017-04-15 2020-12-29 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
WO2018200823A1 (en) 2017-04-28 2018-11-01 Abbott Laboratories Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
CN110651190A (zh) 2017-05-25 2020-01-03 雅培实验室 用早期生物标记物帮助确定是否对已遭受或可能已遭受头部损伤的人受试者执行成像的方法
WO2018222783A1 (en) 2017-05-30 2018-12-06 Abbott Laboratories Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin i and early biomarkers
CA3068041C (en) 2017-07-03 2024-06-25 Abbott Laboratories Improved methods for measuring ubiquitin carboxy-terminal hydrolase l1 levels in blood
CN107748263A (zh) * 2017-08-31 2018-03-02 北京臻惠康生物科技有限公司 一种纤维蛋白溶酶原的新用途及试剂盒
JP7379165B2 (ja) 2017-12-09 2023-11-14 アボット・ラボラトリーズ Gfapとuch-l1との組合せを使用する、ヒト対象における外傷性脳損傷を診断及び査定する一助となるための方法
CN111094983A (zh) 2017-12-09 2020-05-01 雅培实验室 使用胶质细胞原纤维酸性蛋白(gfap)和/或泛素羧基末端水解酶l1(uch-l1)帮助诊断和评价已遭受骨科损伤并已遭受或可能已遭受头部损伤诸如轻度创伤性脑损伤(tbi)的患者的方法
WO2019133717A1 (en) 2017-12-29 2019-07-04 Abbott Laboratories Novel biomarkers and methods for diagnosing and evaluating traumatic brain injury
CN108267598A (zh) * 2018-02-06 2018-07-10 河北省健海生物芯片技术有限责任公司 一种用于肺癌筛查的蛋白芯片的制备方法
WO2019169309A1 (en) * 2018-03-02 2019-09-06 Berger Russell Jay Methods, apparatuses and kits for rapid testing of traumatic brain injuries
WO2020193500A1 (en) * 2019-03-28 2020-10-01 H. Lundbeck A/S Use of a ps396 assay to diagnose tauophaties
US12148604B2 (en) * 2019-04-22 2024-11-19 Amit, Inc. Method for generating data set for training a prediction model and apparatus comprising the prediciton model
CA3150154A1 (en) * 2019-09-05 2021-03-11 Octave Bioscience, Inc. BIOMARKERS FOR THE PREDICTION OF MULTIPLE SCLEROSIS ACTIVITY
KR102443101B1 (ko) * 2020-12-23 2022-09-13 단국대학교 천안캠퍼스 산학협력단 신경 발달 장애의 발병 위험도 예측용 바이오마커 조성물
US12174186B2 (en) * 2021-03-29 2024-12-24 Euroimmun Medizinische Labordiagnostika Ag Method and reagents for the detection of an autoantibody
CN113584021A (zh) * 2021-06-17 2021-11-02 中国人民解放军军事科学院军事医学研究院 用于微波辐射致神经元突触损伤的靶标lncRNA:MSTRG.31953.1
KR102684933B1 (ko) * 2021-08-20 2024-07-16 단국대학교 천안캠퍼스 산학협력단 주의력결핍 과잉행동장애의 진단을 위한 gat-3의 용도
EP4389126A4 (en) * 2021-08-20 2025-05-14 Dankook University Cheonan Campus Industry Academic Cooperation Foundation Pharmaceutical composition for preventing or treating attention deficit/hyperactivity disorder
CN113970643B (zh) * 2021-11-23 2023-06-30 北京大学人民医院 检测抗uch-l1表位的自身抗体的试剂在制备sle血清诊断相关产品中的应用
WO2024107948A1 (en) * 2022-11-16 2024-05-23 Gryphon Bio, Inc. Biomarker panel for brain specific abnormal neurological conditions using biofluid samples
IT202300005046A1 (it) * 2023-03-17 2024-09-17 Fondazione Istituito Neurologico Naz Casimiro Mondino Metodica di individuazione di autoanticorpi diretti contro epitopi conformazionali della proteina proteolipidica (plp) umana nel siero e nel liquor di pazienti con malattie demielinizzanti acquisite
CN116879564A (zh) * 2023-09-06 2023-10-13 暨南大学附属第一医院(广州华侨医院) 基于蛋白质组学及磷酸化蛋白质修饰组学的脊髓损伤生物标志物及其应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4517288A (en) 1981-01-23 1985-05-14 American Hospital Supply Corp. Solid phase system for ligand assay
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
CA1291031C (en) 1985-12-23 1991-10-22 Nikolaas C.J. De Jaeger Method for the detection of specific binding agents and their correspondingbindable substances
US5231000A (en) * 1987-10-08 1993-07-27 The Mclean Hospital Antibodies to A4 amyloid peptide
US5118606A (en) 1988-09-02 1992-06-02 The Regents Of The University Of California Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
EP0436597B1 (en) 1988-09-02 1997-04-02 Protein Engineering Corporation Generation and selection of recombinant varied binding proteins
GB2236186B (en) 1989-08-22 1994-01-05 Finnigan Mat Gmbh Process and device for laser desorption of analyte molecular ions, especially of biomolecules
US5045694A (en) 1989-09-27 1991-09-03 The Rockefeller University Instrument and method for the laser desorption of ions in mass spectrometry
US5780225A (en) 1990-01-12 1998-07-14 Stratagene Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
AU7247191A (en) 1990-01-11 1991-08-05 Molecular Affinities Corporation Production of antibodies using gene libraries
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5698426A (en) 1990-09-28 1997-12-16 Ixsys, Incorporated Surface expression libraries of heteromeric receptors
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
EP1471142B1 (en) 1991-04-10 2008-11-19 The Scripps Research Institute Heterodimeric receptor libraries using phagemids
AU2414092A (en) * 1991-08-01 1993-03-02 Paul H. Voorheis Diagnostic method for alzheimer's disease
WO1993011236A1 (en) 1991-12-02 1993-06-10 Medical Research Council Production of anti-self antibodies from antibody segment repertoires and displayed on phage
US5733743A (en) 1992-03-24 1998-03-31 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
AU685055B2 (en) 1992-05-29 1998-01-15 Rockefeller University, The Method and product for the sequence determination of peptides using a mass spectrometer
US5792664A (en) 1992-05-29 1998-08-11 The Rockefeller University Methods for producing and analyzing biopolymer ladders
ATE242485T1 (de) 1993-05-28 2003-06-15 Baylor College Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
AU696293B2 (en) 1993-12-08 1998-09-03 Genzyme Corporation Process for generating specific antibodies
DK0744958T3 (da) 1994-01-31 2003-10-20 Univ Boston Polyklonale antistofbiblioteker
US5536639A (en) 1994-03-25 1996-07-16 Cephalon, Inc. Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
US5516637A (en) 1994-06-10 1996-05-14 Dade International Inc. Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
JP2978435B2 (ja) 1996-01-24 1999-11-15 チッソ株式会社 アクリロキシプロピルシランの製造方法
US6048703A (en) 1996-11-15 2000-04-11 Cephalon, Inc. Methods for detecting cell apoptosis
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
WO1999051773A1 (en) 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
AU4025300A (en) 1999-03-24 2000-10-09 Packard Bioscience Company Continuous porous matrix arrays
US6589746B1 (en) 1999-10-21 2003-07-08 University Of Cincinnati Method of detecting axonally-derived protein tau in patients with traumatic CNS injury
JP2003070498A (ja) * 2001-07-19 2003-03-11 Pharma Design Inc ユビキチンカルボキシルターミナルヒドロラーゼl1遺伝子異常の検出方法
US20030040660A1 (en) 2001-08-27 2003-02-27 George Jackowski Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
EP2211176A3 (en) * 2002-09-11 2010-12-08 University Of Florida Analyzing nerve cell damage
WO2005004794A2 (en) * 2003-06-09 2005-01-20 Alnylam Pharmaceuticals Inc. Method of treating neurodegenerative disease
JP4885122B2 (ja) 2004-04-15 2012-02-29 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 癌、器官傷害、および筋肉リハビリテーション/運動過剰訓練についての診断の生物マーカーとしてのタンパク質分解マーカー
WO2006107846A2 (en) 2005-04-01 2006-10-12 University Of Florida Research Foundation, Inc. Biomakers of liver injury

Similar Documents

Publication Publication Date Title
JP2007532915A5 (enExample)
Belushkin et al. Rapid and digital detection of inflammatory biomarkers enabled by a novel portable nanoplasmonic imager
Sener et al. Rapid real-time detection of procalcitonin using a microcontact imprinted surface plasmon resonance biosensor
JP2019535015A5 (enExample)
JP2019530875A5 (enExample)
US10386351B2 (en) Methods for detecting and quantifying analytes using gas species diffusion
JP5863074B2 (ja) 膵臓癌を検出するためのマーカー
EP4045912A1 (en) Apparatuses and methods for detection of pancreatic cancer
Aliño et al. Using liquid crystals as a readout system in urinary albumin assays
JP2012529018A (ja) 呼吸困難を起こした患者における細菌感染の検出
US9429569B2 (en) Peptide and protein biomarkers for type 1 diabetes mellitus
Manole et al. Immunoassay techniques highlighting biomarkers in immunogenetic diseases
RU2013158667A (ru) Способ диагностики болезни гоше
WO2009140390A2 (en) Serum markers for type ii diabetes mellitus
US10386365B2 (en) Methods for detecting and quantifying analytes using ionic species diffusion
JPWO2019148054A5 (enExample)
WO2008157518A1 (en) Biomarkers of influenza vaccine response
CN115980369B (zh) 一种基于炎症反应分型的过敏原筛查试剂盒及其应用
CN104360083B (zh) 一种定量检测类风湿因子、抗链球菌溶血素o、c反应蛋白的检测试剂盒
JP2024120022A (ja) 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
WO2007008092A3 (en) Diagnostic kit for the examination of animal sera for the presence of anti-rhd antibodies and a diagnostic kit for detecting the rhd virus
JP2006522336A5 (enExample)
US20210349108A1 (en) Immunoassay for measuring c-peptide
Kao et al. Dual-aptamer assay for C-reactive protein detection by using field-effect transistors on an integrated microfluidic system
JP2012211819A (ja) バイオセンサ